by Marley Wiemers, Washington University School of Medicine Two anti-inflammatory drugs, abatacept and infliximab, reduced deaths among patients hospitalized with severe COVID-19, according to a national study led by Washington University School of Medicine in St. Louis. William G. Powderly, MD, (right) who led the large clinical trial, discusses patient conditions with Maanasi Samant, MD, in the intensive...
Inflammation and metabolic disorders are deeply intertwined. For example, people with inflammatory conditions such as Crohn’s disease and psoriasis are at risk of developing metabolic disorders such as insulin resistance and diabetes. However troubling that connection might seem, it also might point to some promising news. Researchers at Washington University School of Medicine in St. Louis...
AMERICAN SOCIETY FOR MICROBIOLOGY Washington, DC – January 22, 2021 – New research shows that non-steroidal anti-inflammatory drugs (NSAIDs) reduced both antibody and inflammatory responses to SARS-CoV-2 infection in mice. The study appears this week in the Journal of Virology, a publication of the American Society for Microbiology. The research is important because “NSAIDs are arguably the most commonly used...
Nature wades through the literature on the new coronavirus — and summarizes key papers as they appear. Tocilizumab is used to treat rheumatoid arthritis but has also shown promise in treating severe COVID-19.Credit: Alamy 14 January — Two anti-inflammatory drugs prevent COVID deaths Two drugs that dampen the body’s immune response can save the lives of...
Discovery can have potential applications in cancer therapy BECKMAN INSTITUTE FOR ADVANCED SCIENCE AND TECHNOLOGY The Chan group at the Beckman Institute for Advanced Science and Technology has recently developed a probe named CoxFluor, which is able to distinguish between Cyclooxygenase-2, an enzyme that plays a major role in driving the progression of cancer, and...
